Calgene Inc. completed a follow-on offering of 2 million sharesof common stock at $14.75 a share, grossing $29.5 million. Theoffering represents the Davis, Calif., company's fifth round ofpublic financing and was filed with the Securities and ExchangeCommission (SEC) on Dec. 14, 1992. An overallotment option of300,000 shares is still outstanding. Lead underwriters werePaineWebber Inc. and Montgomery Securities.
Upon completion of the offering, Calgene had 24.2 millionshares of common stock outstandingQ25.7 shares on a fullydiluted basis. Calgene (NASDAQ:CGNE) is an agriculturalbiotechnology company which plans to introduce thegenetically engineered Flavr Savr tomato in the U.S. by mid-year.
(c) 1997 American Health Consultants. All rights reserved.